About the Authors
- Katherine E. Price
-
Affiliation Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, United States of America
- Giulia Orazi
-
Affiliation Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, United States of America
- Kathryn L. Ruoff
-
Affiliation Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, United States of America
- Wesley P. Hebert
-
Affiliation Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, United States of America
- George A. O’Toole
-
* E-mail: georgeo@dartmouth.edu (GAO); paul.mastoridis@novartis.com (PM)
Affiliation Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, United States of America
- Paul Mastoridis
-
* E-mail: georgeo@dartmouth.edu (GAO); paul.mastoridis@novartis.com (PM)
Affiliation Novartis Pharmaceutical Corporation, East Hanover, New Jersey, United States of America
Competing Interests
PM is an employee of Novartis Pharmaceutical Corporation, the manufacture of inhaled tobramycin. KEP, KLR, WPH and GAO declare no competing interests. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: PM GAO KEP. Performed the experiments: KLR WPH GO. Analyzed the data: KLR KEP GAO GO. Contributed reagents/materials/analysis tools: GAO. Wrote the paper: KEP GAO PM.